TP53 and cancer: Seven articles met the eligibility criteria for this review, which included 514 patients, finding that overexpression of p53 correlated with statistically significant differences in disease-free (DFS), cancer-specific (CSS), and overall survival (OS), suggesting that p53 is an independent prognostic factor in UTUC.